David C. Seldin, M.D, Ph.D (Deceased) | oneAMYLOIDOSISvoice
Healthcare Professionals

David C. Seldin, M.D, Ph.D (Deceased)

Healthcare Professional
The Amyloidosis Center
Boston University School of Medicine
72 East Concord Street, K-503
Boston, Massachusetts, United States

Dr. Seldin was a Director at the Amyloidosis Center and Chief of the Section of Hematology-Oncology at Boston Medical Center. He earned his medical degree from Harvard Medical School and completed his Residency and Internship in Internal Medicine at the Brigham & Women’s Hospital, followed by a fellowship in hematology and medical oncology at Brigham & Women’s Hospital and Dana Farber Cancer Institute.

Dr. Seldin’s research interests included the causes and cures of amyloidosis. He was an active member of the Stem Cell Transplantation Program at Boston Medical Center, and was an investigator on trials using high dose melphalan chemotherapy and autologous stem cell transplantation, and also on trials for novel agents that have the potential for activity against bone marrow plasma cells in AL, including lenalidomide, pomalidomide, bortezomib, MLN9708, and others. 

Representative Publications:


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.